Tuesday, October 26, 2010

You'll take our inconclusive opinion and like it

After Runi Limary was diagnosed with breast cancer in 2005, she sent a blood sample to Myriad Genetics for testing. "The lab report revealed Limary had an unusual variation in the BRCA 1 gene, but Myriad couldn't determine whether it was a dangerous mutation or a benign, uncommon one." Limary tried to get a second opinion, but couldn't: Myriad holds a monopoly on testing because it own patents on the BRCA genes. More here.

No comments:

Post a Comment